• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Healthcare·VBSN.SW
Share

IVF Hartmann Holding AG Stocks

CHF 132.5Last Updated 10.07.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

CHF 390.70M

CHF 132.5
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers medical devices; hygiene products, body care, hair care, and breast feeding aids; and disinfectants. It also provides household items, including film products, hygiene papers, catering supplies, cleaning papers and textiles, and other household items. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company was founded in 1870 and is headquartered in Neuhausen am Rheinfall, Switzerland. IVF Hartmann Holding AG operates as a subsidiary of Paul Hartmann Finance B.V.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.07.2026 18:05

June was TSMC's best month ever in terms of revenue. Is the AI rally continuing?

13.07.2026 17:31

"You Pay Twice for AI": Microsoft CEO Warns of Dependence on Anthropic and OpenAI

13.07.2026 16:55

Morgan Stanley Expects Earnings Growth Outside the Tech Sector. What to Buy Ahead of Earnings Season?

13.07.2026 16:34

Oninvest Index: Top AI Small-Caps for the First Half of the Year

13.07.2026 15:34

Morning in New York: External Factors Heighten Risks

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026